October 22, 2024
Open to all ISPOR Members and Non-members
Title: IRA Part III: Medicare’s Maximum Fair Prices for the First 10 Negotiated Drugs and Anticipated Cost Savings
Tuesday, October 22, 2024
10:00AM EDT | 2:00PM UTC | 4:00PM CEST
Click here for time zone conversion
Drs. Inma Hernandez and Sean D. Sullivan will compare the recently published Medicare Maximum Fair Prices (MFPs) with net prices before negotiation to discuss the potential magnitude of savings achieved by negotiation. Drs. John O’Brien of the National Pharmaceutical Council and Greg Daniel of Eli Lilly will provide additional context for the MFPs and the estimated cost savings projections. This session will be highly relevant for professionals and researchers in market access, pricing, and HEOR.
The webinar will begin with an explanation of the MFPs and how CMS likely estimated the initial and final price offers. Speakers and panelists will discuss the impact the published MFPs will have on the Medicare Part D prescription drug budget and potential spillover effects into other federal and private sector markets.
Additional Resources
Learning Objectives
- Compare negotiated prices to net prices and other price benchmarks faced by payers before negotiation.
- Identify approaches to estimating the main sources of savings associated from the first 10 drugs selected for negotiation.
- Discuss the potential role of comparative effectiveness research on the derivation of negotiated prices.
Speakers:
Inmaculada (Inma) Hernandez, PhD, Professor, Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, CA, USA
Sean D. Sullivan, PhD, Professor, UW CHOICE Institute, School of Pharmacy, University of Washington, Seattle, WA, USA
John M. O’Brien, PharmD, MPH, President and CEO, National Pharmaceutical Council, Washington, DC, USA
Greg Daniel, PhD, MPH, Vice President, Global Public Policy, Eli Lilly and Company, Washington, DC, USA
Brought to you by: ISPOR
Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar.